About Merida Biosciences
Merida Biosciences develops precision treatments for autoimmune diseases. The company uses a protein engineering platform to create Fc therapeutics. These therapeutics aim to selectively bind to specific antibodies.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Cambridge, United States
Year Founded
2022
Team Size
11-50
Corporate Status
Acquired by Eli Lilly
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
meridabio.com
Domain Registered Date
Jan 29, 2024
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $120,000,000 · Series-A
startupintros.com
- Milestone
Website domain registered
meridabio.com
- Milestone
Company founded
Cambridge, United States
Investors & Backers
Bain Capital Life Sciences
Biotechnology Value Fund
GV
Perceptive Advisors
Third Rock Ventures
Funding History
Series-A
· May 7, 2025
$120,000,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026